Prevention and treatment of haemorrhages due to general or local fibrinolysis in adults and children from one year. Specific indications include: • Haemorrhage caused by general or local fibrinolysis such as: • Menorrhagia and metrorrhagia • Gastrointestinal bleeding • Haemorrhagic urinary disorders, further to prostate surgery or surgical procedures affecting the urinary tract • Ear Nose Throat surgery (adenoidectomy, tonsillectomy, dental extractions) • Gynaecological surgery or disorders of obstetric origin • Thoracic and abdominal surgery and other major surgical intervention such as cardiovascular surgery • Management of haemorrhage due to the administration of a fibrinolytic agent
Short-term use for haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. Local fibrinolysis as occurs in the following conditions: • Prostatectomy and bladder surgery • Menorrhagia • Severe Epistaxis • Conisation of the cervix • Prevention of recurrent hemorrhage in Traumatic hyphaema • Hereditary angioneurotic oedema • Management of dental extraction in haemophiliacs
1. Short-term use for haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. Local fibrinolysis as occurs in the following conditions: a) Prostatectomy and bladder surgery b) Menorrhagia c) Epistaxis d) Conisation of the cervix e) Traumatic hyphaema 2. Hereditary angioneurotic oedema 3. Management of dental extraction in haemophiliacs
Tranexamic Acid is indicated for short term use for haemorrhage or risk of haemorrhage in those with increased fibrinolysis or fibrinogenolysis. Local fibrinolysis as occurs in the following conditions: 1. a) Prostatectomy and bladder surgery b) Menorrhagia c) Epistaxis d) Conisation of the cervix e) Traumatic hyphaema 2. Management of dental extraction in haemophiliacs. 3. Hereditary angioneurotic oedema.